Renascience, Inc. () News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 1287648,
    "name": "Renascience, Inc.",
    "stock_name": "Renascience, Inc.",
    "full_name": "Renascience, Inc.",
    "name_url": "stocks-analysis/renascience-inc",
    "exchange": 121,
    "exchangecode": "TKS",
    "country_id": 23,
    "currency": "JPY",
    "cmp": "1,730.00",
    "chg": "0.00",
    "chgp": "0.00%",
    "dir": 0,
    "prev_price": "1,730.00",
    "mcapval": "25,410.69",
    "mcap": "Small Cap",
    "scripcode": "",
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 2305,
    "indexname": "Japan Nikkei 225",
    "isin": "JP3981100005",
    "curr_date": "Dec 12",
    "curr_time": "",
    "bse_nse_vol": "303.4 k",
    "exc_status": "Active",
    "traded_date": "Dec 12, 2025",
    "traded_date_str": "2025 12 12",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/renascience-inc-1287648-121&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Renascience, Inc. Hits Day Low at JPY 2,001 Amid Price Pressure",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/renascience-inc-hits-day-low-at-jpy-2001-amid-price-pressure-3626922",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/RenascienceInc_priceRelatedfactors_3626922.png",
        "date": "2025-10-16 19:38:40",
        "description": "Renascience, Inc., a small-cap pharmaceutical company, faced a notable stock decline today, reaching an intraday low. Despite a strong year-to-date performance, recent financial metrics reveal challenges, including negative return on equity and significant drops in operating profit and net sales, indicating potential inefficiencies and rising costs."
      },
      {
        "title": "Renascience, Inc. Hits Day High with 12.97% Surge Amid Market Decline",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/renascience-inc-hits-day-high-with-1297-surge-amid-market-decline-3623323",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/RenascienceInc_priceRelatedfactors_3623323.png",
        "date": "2025-10-15 18:20:11",
        "description": "Renascience, Inc., a small-cap biotechnology firm, saw a notable stock price increase on October 14, 2025, amidst a declining market. Over the past week, it has outperformed the Japan Nikkei 225 index significantly, with impressive year-to-date gains, despite facing financial challenges and a negative return on equity."
      },
      {
        "title": "Renascience, Inc. Hits Day High with 15.79% Surge in Stock Price",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/renascience-inc-hits-day-high-with-1579-surge-in-stock-price-3608217",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/RenascienceInc_priceRelatedfactors_3608217.png",
        "date": "2025-10-09 21:16:23",
        "description": "Renascience, Inc. has seen a notable rise in its stock price, achieving significant gains over the past week and year. However, the company faces challenges, including negative return on equity and a substantial decline in net sales, creating a complex financial situation despite its impressive stock performance."
      },
      {
        "title": "Renascience, Inc. Hits Day High with 26.49% Surge in Stock Price",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/renascience-inc-hits-day-high-with-2649-surge-in-stock-price-3604587",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/RenascienceInc_priceRelatedfactors_3604587.png",
        "date": "2025-10-08 17:41:45",
        "description": "Renascience, Inc. has seen a notable increase in its stock price, reaching an intraday high on October 7, 2025. Over the past year, the company has outperformed the Japan Nikkei 225 significantly, despite facing challenges such as declining net sales and negative operating profit."
      },
      {
        "title": "Renascience, Inc. Hits Day High with 10.74% Surge in Stock Price",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/renascience-inc-hits-day-high-with-1074-surge-in-stock-price-3579663",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/9/RenascienceInc_priceRelatedfactors_3579663.png",
        "date": "2025-09-29 15:43:53",
        "description": "Renascience, Inc., a small-cap pharmaceutical company, saw a notable stock increase today, reaching an intraday high. Despite a remarkable year-over-year performance, the company has faced recent challenges, including a decline in stock value over the past month and a significant drop in net sales."
      },
      {
        "title": "Renascience, Inc. Hits Day Low of JPY 1,629 Amid Price Pressure",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/renascience-inc-hits-day-low-of-jpy-1629-amid-price-pressure-3574868",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/9/RenascienceInc_priceRelatedfactors_3574868.png",
        "date": "2025-09-26 18:46:02",
        "description": "Renascience, Inc. faced notable stock volatility, dropping significantly today amid ongoing financial challenges. The company reported a sharp decline in net sales and rising raw material costs, contributing to a negative return on equity. Despite a strong annual performance, its current market position raises investor concerns."
      }
    ],
    "total": 6,
    "sid": "1287648",
    "stock_news_url": "https://www.marketsmojo.com/news/renascience-inc-1287648"
  },
  "announcements": "",
  "corporate_actions": {
    "msg": "No corporate action Found"
  }
}

News and Views

Renascience, Inc. Hits Day Low at JPY 2,001 Amid Price Pressure

2025-10-16 19:38:40

Renascience, Inc., a small-cap pharmaceutical company, faced a notable stock decline today, reaching an intraday low. Despite a strong year-to-date performance, recent financial metrics reveal challenges, including negative return on equity and significant drops in operating profit and net sales, indicating potential inefficiencies and rising costs.

Renascience, Inc. Hits Day High with 12.97% Surge Amid Market Decline

2025-10-15 18:20:11

Renascience, Inc., a small-cap biotechnology firm, saw a notable stock price increase on October 14, 2025, amidst a declining market. Over the past week, it has outperformed the Japan Nikkei 225 index significantly, with impressive year-to-date gains, despite facing financial challenges and a negative return on equity.

Renascience, Inc. Hits Day High with 15.79% Surge in Stock Price

2025-10-09 21:16:23

Renascience, Inc. has seen a notable rise in its stock price, achieving significant gains over the past week and year. However, the company faces challenges, including negative return on equity and a substantial decline in net sales, creating a complex financial situation despite its impressive stock performance.

Renascience, Inc. Hits Day High with 26.49% Surge in Stock Price

2025-10-08 17:41:45

Renascience, Inc. has seen a notable increase in its stock price, reaching an intraday high on October 7, 2025. Over the past year, the company has outperformed the Japan Nikkei 225 significantly, despite facing challenges such as declining net sales and negative operating profit.

Renascience, Inc. Hits Day High with 10.74% Surge in Stock Price

2025-09-29 15:43:53

Renascience, Inc., a small-cap pharmaceutical company, saw a notable stock increase today, reaching an intraday high. Despite a remarkable year-over-year performance, the company has faced recent challenges, including a decline in stock value over the past month and a significant drop in net sales.

Renascience, Inc. Hits Day Low of JPY 1,629 Amid Price Pressure

2025-09-26 18:46:02

Renascience, Inc. faced notable stock volatility, dropping significantly today amid ongoing financial challenges. The company reported a sharp decline in net sales and rising raw material costs, contributing to a negative return on equity. Despite a strong annual performance, its current market position raises investor concerns.

View All News